Literature DB >> 22429205

GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans.

K M Heinemeier1, A L Mackey, S Doessing, M Hansen, M L Bayer, R H Nielsen, A Herchenhan, N M Malmgaard-Clausen, M Kjaer.   

Abstract

Exercise is not only associated with adaptive responses within skeletal muscle fibers but also with induction of collagen synthesis both in muscle and adjacent connective tissue. Additionally, exercise and training leads to activation of the systemic growth hormone/insulin-like growth factor I axis (GH/IGF-I), as well as increased local IGF-I expression. Studies in humans with pathologically high levels of GH/IGF-I, and in healthy humans who receive either weeks of GH administration or acute injection of IGF-I into connective tissue, demonstrate increased expression and synthesis of collagen in muscle and tendon. These observations support a stimulatory effect of GH/IGF-I on the connective tissue in muscle and tendon, which appears far more potent than the effect on contractile proteins of skeletal muscle. However, GH/IGF-I may play an additional role in skeletal muscle by regulation of stem cells (satellite cells), as increased satellite cell numbers are found in human muscle with increased GH/IGF-I levels, despite no change in myofibrillar protein synthesis. Although advanced age is associated with both a reduction in the GH/IGF-I axis activity, and in skeletal muscle mass (sarcopenia) as well as in tendon connective tissue, there is no direct proof linking age-related changes in the musculotendinous tissue to an impaired GH/IGF-I axis.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429205     DOI: 10.1111/j.1600-0838.2012.01459.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  7 in total

1.  Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth.

Authors:  Nathaniel P Disser; Kristoffer B Sugg; Jeffrey R Talarek; Dylan C Sarver; Brennan J Rourke; Christopher L Mendias
Journal:  FASEB J       Date:  2019-09-16       Impact factor: 5.191

Review 2.  Therapeutic use of hormones on tendinopathies: a narrative review.

Authors:  Michele Abate; Matteo Guelfi; Andrea Pantalone; Daniele Vanni; Cosima Schiavone; Isabel Andia; Vincenzo Salini
Journal:  Muscles Ligaments Tendons J       Date:  2016-02-12

3.  The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial.

Authors:  Christopher L Mendias; Elizabeth R Sibilsky Enselman; Adam M Olszewski; Jonathan P Gumucio; Daniel L Edon; Maxwell A Konnaris; James E Carpenter; Tariq M Awan; Jon A Jacobson; Joel J Gagnier; Ariel L Barkan; Asheesh Bedi
Journal:  Am J Sports Med       Date:  2020-05-26       Impact factor: 6.202

Review 4.  Satellite Cells Contribution to Exercise Mediated Muscle Hypertrophy and Repair.

Authors:  Behzad Bazgir; Rouhollah Fathi; Mojtaba Rezazadeh Valojerdi; Paul Mozdziak; Alireza Asgari
Journal:  Cell J       Date:  2016-09-26       Impact factor: 2.479

5.  Specific titin and myomesin domains stimulate myoblast proliferation.

Authors:  Irina V Kravchenko; Vladimir A Furalyov; Vladimir O Popov
Journal:  Biochem Biophys Rep       Date:  2016-12-30

Review 6.  Tendon stem/progenitor cell ageing: Modulation and rejuvenation.

Authors:  Guang-Chun Dai; Ying-Juan Li; Min-Hao Chen; Pan-Pan Lu; Yun-Feng Rui
Journal:  World J Stem Cells       Date:  2019-09-26       Impact factor: 5.326

Review 7.  The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.

Authors:  Farhad Dehkhoda; Christine M M Lee; Johan Medina; Andrew J Brooks
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-13       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.